Clinical Trial Update: TELI TAD - Telithromycin in Tonsillitis in Adolescents and Adults [Phase 3]

View source ↗

Summary

The TELI TAD Phase 3 trial evaluating telithromycin for tonsillitis and pharyngitis in adolescents and adults has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pharyngitis
• Tonsillitis

Drugs mentioned

• Ketek (telithromycin)

Snippet

Sponsor: Sanofi | Conditions: Tonsillitis, Pharyngitis | Phase 3 | Status: TERMINATED